Wang Sheldon 4
4 · Health Insurance Innovations, Inc. · Filed Aug 8, 2018
Insider Transaction Report
Form 4
Wang Sheldon
Chief Technology Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2018-08-06$12.13/sh+5,107$61,948→ 38,782 total - Disposition to Issuer
Class A Common Stock
2018-08-06$43.75/sh−4,459$195,081→ 59,362 total - Exercise/Conversion
Class A Common Stock
2018-08-06$6.77/sh+5,039$34,114→ 63,821 total - Exercise/Conversion
Stock Appreciation Rights
2018-08-06−5,107→ 0 totalExercise: $12.13Exp: 2021-07-14→ Class A Common Stock (5,107 underlying) - Exercise/Conversion
Class A Common Stock
2018-08-06$4.95/sh+20,000$99,000→ 58,782 total - Sale
Class A Common Stock
2018-08-06$43.33/sh−6,593$285,687→ 52,769 total - Exercise/Conversion
Stock Appreciation Rights
2018-08-06−5,039→ 0 totalExercise: $6.77Exp: 2021-05-25→ Class A Common Stock (5,039 underlying) - Exercise/Conversion
Stock Appreciation Rights
2018-08-06−20,000→ 0 totalExercise: $4.95Exp: 2022-07-01→ Class A Common Stock (20,000 underlying)
Footnotes (5)
- [F1]Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $43.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
- [F3]These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
- [F4]These stock-settled stock appreciation rights were granted under the Issuer's Long Term Incentive Plan (the "Plan") and are vested as of the date of this Form 4.
- [F5]These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.